Primary |
Diabetes Mellitus |
18.3% |
Type 2 Diabetes Mellitus |
16.0% |
Insulin-requiring Type Ii Diabetes Mellitus |
9.4% |
Product Used For Unknown Indication |
9.4% |
Insulin-requiring Type 2 Diabetes Mellitus |
8.4% |
Type 1 Diabetes Mellitus |
7.9% |
Hypertension |
6.9% |
Ill-defined Disorder |
5.7% |
Off Label Use |
3.0% |
Chronic Obstructive Pulmonary Disease |
2.2% |
Drug Use For Unknown Indication |
2.2% |
Blood Pressure Increased |
2.0% |
Asthma |
1.7% |
Bronchiectasis |
1.2% |
Diabetes Mellitus Insulin-dependent |
1.2% |
Gastrooesophageal Reflux Disease |
1.2% |
Blood Cholesterol Increased |
1.0% |
Blood Pressure |
0.7% |
Cardiovascular Event Prophylaxis |
0.7% |
Dyspepsia |
0.7% |
|
Blood Glucose Increased |
11.6% |
Hypoglycaemic Unconsciousness |
11.6% |
Blood Glucose Decreased |
10.7% |
Hypoglycaemia |
6.3% |
Loss Of Consciousness |
5.4% |
Medication Error |
5.4% |
Vision Blurred |
5.4% |
Myocardial Infarction |
4.5% |
Nausea |
4.5% |
Victim Of Crime |
4.5% |
Injection Site Irritation |
3.6% |
Product Quality Issue |
3.6% |
Victim Of Homicide |
3.6% |
Wrong Drug Administered |
3.6% |
Blood Glucose Fluctuation |
2.7% |
Convulsion |
2.7% |
Death |
2.7% |
Dyspnoea |
2.7% |
Incorrect Storage Of Drug |
2.7% |
Mental Status Changes |
2.7% |
|
Secondary |
Type 2 Diabetes Mellitus |
25.8% |
Diabetes Mellitus |
11.7% |
Type 1 Diabetes Mellitus |
9.2% |
Insulin-requiring Type 2 Diabetes Mellitus |
7.9% |
Insulin-requiring Type Ii Diabetes Mellitus |
6.7% |
Product Used For Unknown Indication |
5.8% |
Drug Use For Unknown Indication |
4.6% |
Hypertension |
4.2% |
Prostatomegaly |
4.2% |
Blood Cholesterol Increased |
2.9% |
Arrhythmia |
2.1% |
Oedema Peripheral |
2.1% |
Anaemia |
1.7% |
Insomnia |
1.7% |
Nasal Congestion |
1.7% |
Oedema |
1.7% |
Pain In Extremity |
1.7% |
Pain Management |
1.7% |
Restless Legs Syndrome |
1.7% |
Blood Pressure |
1.3% |
|
Hypoglycaemic Unconsciousness |
17.6% |
Fatigue |
11.8% |
Pancreatitis |
7.8% |
Vision Blurred |
7.8% |
Cerebrovascular Accident |
5.9% |
Wrong Drug Administered |
5.9% |
Blood Glucose Increased |
3.9% |
Diabetes Mellitus Inadequate Control |
3.9% |
Dyspnoea |
3.9% |
Glycosylated Haemoglobin Increased |
3.9% |
Malaise |
3.9% |
Transient Ischaemic Attack |
3.9% |
Urinary Tract Infection |
3.9% |
White Blood Cells Urine Positive |
3.9% |
Anaphylactic Reaction |
2.0% |
Angina Pectoris |
2.0% |
Cardiac Failure |
2.0% |
Cardiac Failure Congestive |
2.0% |
Circumstance Or Information Capable Of Leading To Medication Error |
2.0% |
Convulsion |
2.0% |
|
Concomitant |
Product Used For Unknown Indication |
61.5% |
Drug Use For Unknown Indication |
12.7% |
Diabetes Mellitus |
6.3% |
Hypertension |
3.2% |
Type 2 Diabetes Mellitus |
2.5% |
Prophylaxis |
2.2% |
Pain |
1.7% |
Diabetes Mellitus Non-insulin-dependent |
1.3% |
Blood Cholesterol Increased |
1.0% |
Depression |
1.0% |
Rheumatoid Arthritis |
0.9% |
Atrial Fibrillation |
0.8% |
Type 1 Diabetes Mellitus |
0.8% |
Cardiac Operation |
0.7% |
Arthritis |
0.6% |
Cardiac Disorder |
0.6% |
Renal Transplant |
0.6% |
Renal Cell Carcinoma |
0.6% |
Osteoporosis |
0.5% |
Anxiety |
0.5% |
|
Weight Decreased |
19.0% |
Vomiting |
10.8% |
Blood Glucose Increased |
8.5% |
Nausea |
7.6% |
Weight Increased |
5.8% |
Death |
5.0% |
Drug Ineffective |
4.1% |
Pain |
4.1% |
Renal Failure |
3.8% |
Thrombosis |
3.8% |
Myocardial Infarction |
3.2% |
Renal Failure Acute |
3.2% |
Type 2 Diabetes Mellitus |
2.9% |
White Blood Cell Count Decreased |
2.9% |
Therapeutic Response Decreased |
2.6% |
Thrombocytopenia |
2.6% |
Urinary Tract Infection |
2.6% |
Vision Blurred |
2.6% |
Tremor |
2.3% |
Urosepsis |
2.3% |
|